Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy.

Schmitt, Marisa; Sinnberg, Tobias; Niessner, Heike; Forschner, Andrea; Garbe, Claus; Macek, Boris; Nalpas, Nicolas C

Schmitt, Marisa; Sinnberg, Tobias; Niessner, Heike; Forschner, Andrea; Garbe, Claus; Macek, Boris; Nalpas, Nicolas C.

Afiliação

Schmitt M; Quantitative Proteomics, University of Tübingen, 72074 Tübingen, Germany.
Sinnberg T; Division of Dermatooncology, University of Tübingen, 72074 Tübingen, Germany.
Niessner H; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tuebingen, 72074 Tübingen, Germany.
Forschner A; Division of Dermatooncology, University of Tübingen, 72074 Tübingen, Germany.
Garbe C; Division of Dermatooncology, University of Tübingen, 72074 Tübingen, Germany.
Macek B; Division of Dermatooncology, University of Tübingen, 72074 Tübingen, Germany.
Nalpas NC; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tuebingen, 72074 Tübingen, Germany.

Cancers (Basel) ; 13(21)2021 Oct 28.

Article em En | MEDLINE | ID: mdl-34771574

Palavras-chave

immunotherapy; mass spectrometry; melanoma; proteogenomics; whole exome sequencing

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google